OrsoBio, Inc. ("OrsoBio" or "the Company"), a clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic disorders, today announced positive topline data from a ...
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...
Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with ...
Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...
Smithsonian Magazine on MSN
The High-Stakes Quest to Make Snakebites Survivable Took Leaps Forward This Year, With Promising New Avenues to Safer Antivenoms
A wave of fresh science is challenging a century-old treatment and offering hope to the people snakebites harm most—often far ...
News-Medical.Net on MSN
First-of-its-kind mRNA system switches on therapeutic genes inside targeted cells
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback